Filing Details

Accession Number:
0001321732-24-000122
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-19 20:04:59
Reporting Period:
2024-11-15
Accepted Time:
2024-11-19 20:04:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1321732 Penumbra Inc PEN Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1751980 Johanna Roberts One Penumbra Place
Alameda CA 94502
Evp, Gen. Counsel & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-15 4,290 $0.00 64,778 No 4 A Direct
Common Stock Disposition 2024-11-15 134 $237.84 64,644 No 4 F Direct
Common Stock Disposition 2024-11-18 18 $235.98 64,626 No 4 S Direct
Common Stock Disposition 2024-11-18 36 $236.59 64,590 No 4 S Direct
Common Stock Disposition 2024-11-18 45 $238.90 64,545 No 4 S Direct
Common Stock Disposition 2024-11-18 376 $239.93 64,169 No 4 S Direct
Common Stock Disposition 2024-11-18 112 $240.82 64,057 No 4 S Direct
Common Stock Disposition 2024-11-18 13 $241.69 64,044 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. On November 15, 2024, the Reporting Person was granted 4,290 restricted stock units (RSUs) under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on November 15, 2025, subject to continued service by the Reporting Person on the applicable vesting date.
  2. A portion of these shares is subject to vesting.
  3. Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person.
  4. The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  5. This transaction was executed in multiple trades at prices ranging from $235.40 to $236.35. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $236.48 to $236.86. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $238.60 to $239.37. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $239.40 to $240.37. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  9. This transaction was executed in multiple trades at prices ranging from $240.40 to $241.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  10. This transaction was executed in multiple trades at prices ranging from $241.53 to $241.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.